Back to News
Market Impact: 0.15
ARS PHARMACEUTICALS DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Reminds ARS Pharmaceuticals Investors to Contact the Firm Before October 5th Seeking Lead Plaintiff Role
Source: globenewswire.com
Legal & Litigation
Bragar Eagel & Squire is soliciting ARS securityholders who purchased or acquired shares between March 9, 2026 and June 24, 2026 to discuss potential legal rights. The notice indicates a possible securities-related investigation or litigation, but provides no allegations, damages, or financial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
More News
- Mark Ruffalo says Paramount’s $111 billion Warner Bros. deal ‘Will stifle creativity, weaken free speech, and cost people their jobs’
- States, cities sue U.S. agencies over weaker vehicle fuel economy rules
- David Ellison goes minimalist with his new name for his Paramount-Skydance-Warner-Bros-Discovery empire
- Paramount-WBD Will Now Be Called Skydance, David Ellison Reveals
- Paramount and Warner Bros. Discovery to Merge Into Skydance (SKYD). Will Skydance Achieve David Ellison’s "Quality Storytelling" Vision?
- Lyft agrees to pay $272.5 million to settle worker classification lawsuit